BIO-TECHNE AND ALZpath ANNOUNCE STRATEGIC PARTNERSHIP TO ADVANCE NEURODEGENERATIVE DISEASE RESEARCH

Go back to BIO-TECHNE AND ALZpath ANNOUNCE STRATEGIC PARTNERSHIP TO ADVANCE NEURODEGENERATIVE DISEASE RESEARCH
Techne Corp (NASDAQ: TECH) Delayed: 72.38 -0.1 (0.14%)
Previous Close $72.48    52 Week High $117.42 
Open $72.36    52 Week Low $79.95 
Day High $72.51    P/E 23.42 
Day Low $72.29    EPS $3.09 
Volume 1,910,239